DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Vericiguat
Vericiguat
Durham E-Theses
Merck Announces U.S. FDA Approval of VERQUVO® (Vericiguat)
Treatment of Children with Pulmonary Hypertension. Expert Consensus Statement on the Diagnosis and Treatment of Paediatric Pulmonary Hypertension
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
A Study of Vericiguat in Participants with Heart Failure with Reduced Ejection Fraction (Hfref) (MK-1242-001) (VICTORIA)
Download the VICTORIA Faqs Document (PDF)
WO 2018/073144 Al 26 April 2018 (26.04.2018) W !P O PCT
VICTORIA Trial Summary- Vericiguat in Heart Failure June 2020
Safety, Pharmacodynamic, and Pharmacokinetic Characterization of Vericiguat: Results from Six Phase I Studies in Healthy Subjects
Study Protocol
Current Modulation of Guanylate Cyclase Pathway Activity—Mechanism and Clinical Implications
Updates in Pharmacotherapy of Heart Failure with Reduced Ejection Fraction
Verquvo; INN Vericiguat
News Release Germany Phone +49 214 30-1 Media.Bayer.Com
Drug Monograph
Bioactive Compound Library Plus (96-Well)
Alphabetical Listing by Name Dod UNIFORM OUTPATIENT
The Impact of the Nitric Oxide (NO)/Soluble Guanylyl Cyclase (Sgc) Signaling Cascade on Kidney Health and Disease: a Preclinical Perspective
Top View
Vericiguat) Tablets, for Oral Use ------CONTRAINDICATIONS------Initial U.S
Integrated Clinical Study Protocol No. BAY 1021189 / 15371 06 JUL 2014 Version 2.0 Page: 1 of 95
Verquvo (Vericiguat).Pdf
ATC Vet 2021 Atccode Atcdescription Atcdescriptionsi QA ALIMENTARY TRACT and METABOLISM ZDRAVILA ZA BOLEZNI PREBAVIL in PRESNOVE
Universidade Federal Do Ceará Faculdade De Medicina Departamento De Fisiologia E Farmacologia Programa De Pós-Graduação Em Farmacologia
Clinical Study Synopsis
INN Vericiguat
214377Orig1s000
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Verquvo® (Vericiguat) NOTICE
ENTRESTO™ (Sacubitril and Valsartan) VERQUVO™ (Vericiguat)
Vericiguat (Available As VERQUVO™) Pivotal Clinical Data Summary Indications and Usage
Review Contemporary Pharmacological Treatment Strategies For
WO 2017/106175 A2 22 June 2017 (22.06.2017) W P O P C T
Verquvo – Criteria
NCT Number: NCT02861534 Document Date: 20-Dec-2017 Product: MK-1242 (Vericiguat) 1 Protocol/Amendment No.: 001-04
JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure ― Digest Version ―
Verquvo (Vericiguat) C21141-A
Soluble Guanylate Cyclase Stimulator Vericiguat Enhances Long-Term Memory in Rats Without Altering Cerebral Blood Volume
The VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) Trial Paul W
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
Welcome Letter